Distance Learning Course Catalog - Cicatelli Associates Inc.

CAIOnline Course Profile for
The ABCs of Chlamydia: A Region II IPP Online Educational Resource

This course is no longer available on line

Description:

The ABCs of Chlamydia: A Region II IPP Online Educational Resource was developed with the goal of reducing the incidence and prevalence of chlamydia and gonorrhea and associated sequelae by teaching early detection through routine screening. The course includes a detailed descriptions of the various testing technologies, treatment options, and client interaction strategies. This course places emphasis on Region II, which includes New York, New Jersey, Puerto Rico, and the U.S. Virgin Islands.

This web-based training was developed by Cicatelli Associates Inc. (CAI) along with the Region II Infertility Prevention Project (IPP) and Region II STD/HIV Prevention Training Center (PTC), with funding from the Centers for Disease Control and Prevention (CDC).

Price:

There is no registration fee for this course. Please note, however, that a nominal fee is charged for continuing education credits, which are optional.

*Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through Cicatelli Associates Incorporated (CAI). CAI is accredited by the ACCME to provide continuing medical education to physicians.

Cicatelli Associates, Inc., is an approved provider of continuing nursing education by the New York State Nurses Association Council on Continuing Education, which is accredited as an approver of continuing education in nursing by the American Nurses Credential Commission on Accreditation.

*Continuing education credits are not currently available for this course.

Authors:

Kathy Gates-Ferris, M.S., M.P.A., Region II IPP Coordinator
Tammy Lee, Research/Evaluation Associate
Erica Schachne Pal, M.P.A., formerly Region II IPP Deputy Coordinator

Objectives:

Promote the importance of routine annual chlamydia screening for all sexually active females ages 25 years or younger.
Characterize national, regional, and local epidemiology of chlamydia, with particular attention to Region II data.
Describe the sequelae of chlamydia in women, men and infants.
Define who is at risk and who should be screened for chlamydia based on current guidelines.
Identify amplification and nonamplification testing technologies for chlamydia testing.
Discuss the benefits of Nucleic Acid Amplification Tests (NAATs) as a highly sensitive and specific method for detection of chlamydia.
Define the treatment for chlamydia.
Identify effective client interaction strategies related to chlamydia screening and behavioral counseling.
Access additional resources and educational materials related to chlamydia.

System Requirements:

Windows 95 and above, Mac OS 9 and X.
Minimum of 64 MB of RAM.
Microsoft Word, Adobe Acrobat Reader.
Minimum 56K modem.
Browser - IE version 5 or higher, Netscape version 6 or higher.
Real One Player (to view videos)

Course Outline:

Course Outline
Welcome	Development, continuing education, hardware/software, and contact information.
Continuing Education	Provides information and forms necessary to obtain continuing education credits.
Course Overview	Explains how to get around the course, outlines the course objectives and contents, describe the intended audience, and provide an estimate of the time it might take to complete the entire course.
Need for Ct Tests	Chlamydia is the most common bacterial sexually transmitted disease (STD) and the most commonly reported communicable infection in the United States. Because chlamydia is primarily asymptomatic disease, it often goes unnoticed and if left untreated, can cause pelvic inflammatory disease (PID) in women, and result in infertility in both men and women. This module covers how clinicians can identify clients who are at risk for chlamydia.
Ct Screening	Routine chlamydia screening enables detection of asymptomatic infection, reduction in chlamydia prevalence, and reduction in associated sequelae. This module reviews ways clinicians can identify clients who should be tested for chlamydia.
Risk Reduction	Providers must make a commitment to discuss this important yet sensitive topic with their clients, and be sure to create a "safe space" where clients feel comfortable and unashamed to discuss a topic that is deeply personal. This may require that providers first assess their own feelings around the issue, and do what is required to make themselves feel more comfortable discussing it. This module will provide clinicians with the necessary information and tools to encourage clients to reduce risky behavior.
Lab Technologies	Many clinical providers are not aware of the numerous test technologies for chlamydia that are currently available. The purpose of this module is to provide a brief overview of the various test technologies and related issues to consider when making a test selection. In addition, included in this module are several guidelines and recommendations developed by the Region II Infertility Prevention Project’s Laboratory Committee, which is comprised of national and regional expert laboratorians.
Treatment	This module provides the necessary these tools, skills and knowledge to successfully treat chlamydia.
Client Interaction	Training of health care providers should ideally seek to decrease anxiety and personal difficulty with the sexual aspects of health care, increase knowledge, increase awareness of personal biases, and increase tolerance and understanding of the diversity of sexual expression.
Final test	Required for continuing education credits.
Course Evaluation	Required for continuing education credits. Participants provide feedback on the course.
Glossary	Glossary of terms and acronyms used in the course.
Toolbox	All forms, printouts referenced in the course.
Help	Quick access to course navigation questions/answers.

Audience:

The target audience for this course is clinicians who perform chlamydia screening in the following settings: family planning and STD clinics, private practices, managed care organizations, and other health care settings. The course content may benefit health care organization administrators who make decisions regarding chlamydia screening protocols and testing technologies. Geographically, the audience is nationwide. However, some epidemiological data and screening guidelines cater to DHHS Region II—New York (including New York City), New Jersey, Puerto Rico, and the Virgin Islands.

*Continuing Education Credits:

*Continuing education credits are no longer available for this course.

Cicatelli Associates Inc. Homepage

Cicatelli Associates Incorporated, 505 Eighth Avenue, Suite 1600, New York, NY 10018
phone: (212) 594-7741 / fax: (212) 629-3321
http://www.cicatelli.org

support CAI

site map